Title of the centre:
WHO Collaborating Center on HIV and viral hepatitis
Director / Head:
Professor Jens Lundgren
Mr Jesper Grarup
Copenhagen HIV Programme, Faculty of science
Institute of International Health, Immunology and Microbiology, University of Copenhagen
Blegdamsvej 3G, Bld. 21/1
+45 3545 5757
+45 3545 5758
Date of Designation:
Terms of Reference:
- To assist WHO to develop global normative guidance, advise on research needs, regional context and provide regional evidence-based data from cohort-studies, clinical trials and regional initiatives (OSER 2.002).
- To assist WHO to provide technical support to the countries of central and eastern Europe and central Asia (CEECA) in treatment and care of HIV and viral hepatitis, including service delivery and in adaptation of the WHO guidelines to the countries’ context and capacity (OSER 2.001).
- To contribute to the WHO efforts in building sustainable capacity in treatment and care of HIV and viral hepatitis, in CEECA through training, act as a knowledge resource (OSER 2.001)
- To network and build strategic partnership promoting evidence-based approach and disseminating evidence-based data and approach to HIV, viral hepatitis treatment and care in the CEECA region (OSEW 2.001).
- Pharmaceuticals (including essential drugs and medicines)
Types of activity:
- Product development (guidelines; manual; methodologies; etc.)
- Training and education
- Implementation of WHO programmes and activities at country level
Ower: 2.1 - Guidelines, policy, strategy and other tools developed for prevention of, and treatment and care for patients with, HIV/AIDS, tuberculosis and malaria, including innovative approaches for increasing coverage of the interventions among poor people, and hard-to-reach and vulnerable populations.
Ower: 2.2 - Policy and technical support provided to countries towards expanded gender-sensitive delivery of prevention, treatment and care interventions for HIV/AIDS, tuberculosis and malaria, including integrated training and service delivery; wider service-provider networks; and strengthened laboratory capacities and better linkages with other health services, such as those for sexual and reproductive health, maternal, newborn and child health, sexually transmitted infections, nutrition, drug-dependence treatment service respiratory care, neglected diseases and environmental health.
Ower: 2.3 - Global guidance and technical support provided on policies and programmes in order to promote equitable access to essential medicines, diagnostic tools and health technologies of assured quality for the prevention and treatment of HIV/AIDS, tuberculosis and malaria, and their rational use by prescribers and consumers, and, in order to ensure uninterrupted supplies of diagnostics, safe blood and blood products, injections and other essential health technologies and commodities.
DONOGHOE Martin Christopher
VITORIA Marco Antonio De Avila
+41 22 791 1949
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork